LARGE2 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: This indicates that data obtained from α-dystroglycanopathy hiPSCs with LARGE mutations should be interpreted with caution, because LARGE2 enzymatic activity could be rescuing functional glycosylation of αDG.